Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research

Pharmacoepidemiology and Drug Safety

Volumn 6, Issue SUPPL. 3, 1997, Pages

  Schneeweiss, Sebastian ^a   Stürmer, Til ^b,c   Maclure, Malcolm ^c,d  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d MINISTRY OF HEALTH   (Canada)

Author keywords

Case crossover; Case time control; Epidemiologic methods; Pharmacoepidemiology; Study design

Indexed keywords

NIFEDIPINE;

ADVERSE DRUG REACTION; CASE CONTROL STUDY; COHORT ANALYSIS; CONFERENCE PAPER; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HUMAN; LONG TERM EXPOSURE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0030831605     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199710)6:3+3.0.CO;2-S     Document Type: Conference Paper

References (18)

1. Yusef, S., Held, P. and Furberg, C. Update of efffects of calcuim antagonists in myocardial infarction or angina in light of the second Danish verapamil infarction trial (DAVIT-II) and other recent studies. American Journal of Cardiology 1991; 67: 1295-1297.
2. O'Mailia, J. J., Sander, G. E. and Giles, T. D. Nifedipine associated myocardial ischemia or infarction in the treatment of hypertensive emergencies. Annals of Internal Medicine 1987; 107: 185-186.
3. Psaty, B. M., Heckett, S. R., Koepsell, T. D., et al. The risk of myocardial infarction associated with antihypertensive drug therapy. Journal of the American Medical Association 1995; 274: 620-625.
4. Beevers, D. G. and Sleight, P. Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk? British Medical Journal 1996; 312: 1143-1145.
5. Gong, L., Zhang, W., Zhu, Y., et al. Shanghai trial in the elderly (STONE). Journal of Hypertension 1996; 14: 1237-1245.
6. Willich, S. N., Lewis, M., Löwel, H., Arntz, H., Schubert, F., Schröder, R. For Triggers and Mechanisms of Myocardial Infarction Study Group. Physical exertion as a trigger of acute myocardial infarction. New England Journal of Medicine 1993; 329: 1684-1690.
7. Paffenbarger, R. S. Jr, Wing, A. L. and Hyde, R. T. Physical activity as an index of heart attack risk in college alumni. American Journal of Epidemiology 1978; 108: 161-175.
8. Wacholder, S. Practical considerations in choosing between case-cohort and nested case-control designs. Epidemiology 1991; 2: 155-158.
9. Rothman, K. Modern Epidemiology. Little Brown, Boston, 1986.
10. Greenland, S. The effect of misclassification in the presence of covariates. American Journal of Epidemiology 1980; 112: 564-569.
11. Guess, H. A. Behavior of the exposure odds ratio in a case-control study when the hazard function is not constant over time. Journal of Clinical Epidemiology 1989; 42: 1179-1184.
12. Miettinen, O. Estimability and estimation in case-referent studies. American Journal of Epidemiology 1976; 103: 226-235.
13. Maclure, M. The case-crossover design: a method for studying transient effects on the risk of acute events. American Journal of Epidemiology 1991; 113: 144-153.
14. Feldmann, U. Epidemiologic assessment of risks of adverse reactions associated with intermittent exposure. Biometrics 1993; 49: 419-428.
15. Mittleman, M. A., Maclure, M. and Robins, J. Control sampling strategies for case-crossover studies: an assessment of relative efficiency. American Journal of Epidemiology 1995; 142: 91-98.
16. Suissa, S. The case-time-control design. Epidemiology 1995; 6: 248-253.
17. Greenland, S. Confounding and exposure trends in case-crossover and case-time-control designs. Epidemiology 1996; 7: 231-239.
18. Hasford, J. Drug risk assessment: a case for large trials with lean protocol. Pharmacoepidemiology and Drug Safety 1994; 3: 321-327.